| The tumour microenvironment as an integrated framework to understand cancer biology R Burgos-Panadero, F Lucantoni, E Gamero-Sandemetrio, ... Cancer Letters 461, 112-122, 2019 | 77 | 2019 |
| A three-dimensional bioprinted model to evaluate the effect of stiffness on neuroblastoma cell cluster dynamics and behavior E Monferrer, S Martín-Vañó, A Carretero, A García-Lizarribar, ... Scientific reports 10 (1), 6370, 2020 | 48 | 2020 |
| Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma R Burgos-Panadero, I Noguera, A Cañete, S Navarro, R Noguera BMC cancer 19, 1-10, 2019 | 46 | 2019 |
| Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line A López-Carrasco, S Martín-Vañó, R Burgos-Panadero, E Monferrer, ... Journal of Experimental & Clinical Cancer Research 39, 1-13, 2020 | 34 | 2020 |
| Integrating the tumor microenvironment into cancer therapy S Sanegre, F Lucantoni, R Burgos-Panadero, L de La Cruz-Merino, ... Cancers 12 (6), 1677, 2020 | 31 | 2020 |
| High Oct4 expression: implications in the pathogenesis of neuroblastic tumours E Monferrer, R Burgos-Panadero, M Blanquer-Maceiras, A Cañete, ... BMC cancer 19, 1-8, 2019 | 17 | 2019 |
| Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma R Burgos-Panadero, SH El Moukhtari, I Noguera, C Rodríguez-Nogales, ... International Journal of Pharmaceutics 608, 121058, 2021 | 14 | 2021 |
| The topology of vitronectin: A complementary feature for neuroblastoma risk classification based on computer‐aided detection P Vicente‐Munuera, R Burgos‐Panadero, I Noguera, S Navarro, ... International Journal of Cancer 146 (2), 553-565, 2020 | 14 | 2020 |
| The oral KIF11 inhibitor 4SC‐205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models M Masanas, N Masiá, L Suárez‐Cabrera, M Olivan, A Soriano, B Majem, ... Clinical and translational medicine 11 (10), e533, 2021 | 13 | 2021 |
| Global loss of cellular m6A RNA methylation following infection with different SARS-CoV-2 variants R Vaid, A Mendez, K Thombare, R Burgos-Panadero, R Robinot, ... Genome Research 33 (3), 299-313, 2023 | 12 | 2023 |
| Digital image analysis applied to tumor cell proliferation, aggressiveness, and migration-related protein synthesis in neuroblastoma 3D models E Monferrer, S Sanegre, S Martín-Vañó, A García-Lizarribar, ... International journal of molecular sciences 21 (22), 8676, 2020 | 10 | 2020 |
| Una visión integral del cáncer (I). Microambiente tumoral: estudio, clasificación y reprogramación R Noguera, R Burgos-Panadero, E Gamero-Sandemetrio, ... Revista Española de Patología 52 (2), 92-102, 2019 | 9 | 2019 |
| METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma R Vaid, K Thombare, A Mendez, R Burgos-Panadero, A Djos, ... Nucleic Acids Research 52 (5), 2648-2671, 2024 | 5 | 2024 |
| An integral view of cancer (II). Fields of investigation and emerging biomarkers R Noguera, R Burgos-Panadero, E Gamero-Sandemetrio, ... Revista Espanola de Patologia: Publicacion Oficial de la Sociedad Espanola …, 2019 | 4 | 2019 |
| m6A modification of TERRA RNA is required for telomere maintenance and is a therapeutic target for ALT positive Neuroblastoma R Vaid, K Thombare, A Mendez, R Burgos-Panadero, A Djos, ... bioRxiv, 2022.12. 09.519591, 2022 | 2 | 2022 |
| Una visión integral del cáncer (II). Campos de estudio y biomarcadores emergentes R Noguera, R Burgos-Panadero, E Gamero-Sandemetrio, ... Revista Española de Patología 52 (4), 222-233, 2019 | 2 | 2019 |
| An integral view of cancer (I). The study, classification and reprogramming of the tumoral microclimate R Noguera, R Burgos-Panadero, E Gamero-Sandemetrio, ... Revista Espanola de Patologia: Publicacion Oficial de la Sociedad Espanola …, 2019 | 2 | 2019 |
| The prognostic relevance of a gene expression signature in MRI-defined highly vascularized glioblastoma V Montosa-i-Micó, M del Mar Álvarez-Torres, R Burgos-Panadero, ... Heliyon 10 (11), 2024 | | 2024 |
| METTL3/MYCN cooperation drives m6A modification during trunk neural crest differentiation and represents a therapeutic vulnerability in MYCN-amplified … K Thombare, R Vaid, A Mendez, P Pucci, R Burgos-Panadero, ... | | 2023 |
| METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastoma K Thombare, R Vaid, P Pucci, A Mendez, R Burgos-Panadero, ... bioRxiv, 2023.10. 06.561194, 2023 | | 2023 |
